Alnylam Pharmaceuticals (ALNY)
(Delayed Data from NSDQ)
$152.78 USD
+3.48 (2.33%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $152.78 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ALNY 152.78 +3.48(2.33%)
Will ALNY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ALNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALNY
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
ALNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates
Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?
Gear Up for Alnylam (ALNY) Q1 Earnings: Wall Street Estimates for Key Metrics
Other News for ALNY
The 'Undercovered' Dozen From June 1-6
Alnylam, Pliant among stocks yet to face Q2 catalysts: Wells Fargo
Vir gains on early mid-stage data for hepatitis candidate
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
Upcoming Pivotal HELIOS-B Data Looms Large For Alnylam's Valuation